ArticleHuman molecular genetics2020

Treatment with JQ1, a BET bromodomain inhibitor, is selectively detrimental to R6/2 Huntington's disease mice.

Amanda J Kedaigle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.